Armed with a new $10 million grant, a multi-center “dream team’’ of scientists, led by UCSF, is embarking on a groundbreaking undertaking to overcome therapeutic resistance and revolutionize treatment for patients with advanced prostate cancer.
September 18, 2012
A once-promising discovery linking prostate cancer to an obscure retrovirus derived from mice was the result of an inadvertent laboratory contamination, a forensic analysis of tissue samples and lab experiments – some dating back nearly a decade – has confirmed.
June 04, 2012
A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease, according to results of a UCSF-led study.
February 22, 2012
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at UCSF have discovered how a protein “master regulator” goes awry, leading to metastasis, the fatal step of cancer.
February 01, 2012
Scientists at UCSF have identified nearly 200 genes in the healthy prostate tissue of men with low-grade prostate cancer that may help explain how physical activity improves survival from the disease.
October 25, 2011
New studies of vitamin supplements, prostate cancer risk in men and mortality in women have yielded disappointing results. Some researchers remain optimistic about identifying dietary and lifestyle interventions that are beneficial to health.
October 19, 2011
A rekindled controversy over the use of PSA screening to help detect prostate cancer highlights the different perspectives physicians may take in framing issues, evaluating studies and deciding on best practices.
September 01, 2011
For the first time in his life, 50-year-old Art Wagner is growing a beard to raise awareness of prostate cancer after he was successfully treated at UCSF Medical Center.
May 24, 2011
A study of 1,455 U.S. men diagnosed with early-stage prostate cancer has found a link between brisk walking and lowered risk of prostate cancer progression, according to scientists at UCSF and the Harvard School of Public Health.
May 05, 2011
Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.